Joannah Score

Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Genome-wide analysis defines genetic determinants of MPN subtypes and identifies a sex-specific association at CDH22/CD40.

Genome-wide analysis defines genetic determinants of MPN subtypes and identifies a sex-specific association at CDH22/CD40.

Journal: Blood
Published: January 17, 2025

Is cancer latency an outdated concept? Lessons from chronic myeloid leukemia.

Is cancer latency an outdated concept? Lessons from chronic myeloid leukemia.

Journal: Leukemia
Published: June 06, 2020

Mutational mechanisms of EZH2 inactivation in myeloid neoplasms.

Mutational mechanisms of EZH2 inactivation in myeloid neoplasms.

Journal: Leukemia
Published: September 05, 2019

PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia.

PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia.

Journal: Leukemia
Published: October 01, 2018

Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia.

Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia.

Journal: Leukemia
Published: July 29, 2017

Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locus.

Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locus.

Journal: Leukemia
Published: April 30, 2015

Detection of leukemia-associated mutations in peripheral blood DNA of hematologically normal elderly individuals.

Detection of leukemia-associated mutations in peripheral blood DNA of hematologically normal elderly individuals.

Journal: Leukemia
Published: January 29, 2015

Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes.

Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes.

Journal: Annals of hematology
Published: September 11, 2014

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.

Journal: Leukemia
Published: January 11, 2014

Megalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutations.

Megalencephaly syndromes: exome pipeline strategies for detecting low-level mosaic mutations.

Journal: PloS one
Published: August 29, 2013

Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer.

Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer.

Journal: Nature genetics
Published: July 10, 2013

Distribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patients.

Distribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patients.

Journal: Leukemia
Published: April 17, 2013
Showing 1-12 of 21

Last Updated: 09/26/2026